Patent directory · USPTO A61K / A61P
Patents matching “Kymera Therapeutics, Inc.”
29 pharma patents match "Kymera Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 29 pharmaceutical patents matching "Kymera Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12258341
IRAK degraders and uses thereof
granted -
US 12187744
IRAK4 degraders and synthesis thereof
granted -
US 12171768
IRAK4 degraders and uses thereof
granted -
US 12168057
IRAK degraders and uses thereof
granted -
US 12150995
IRAK degraders and uses thereof
granted -
US 12097261
CDK2 degraders and uses thereof
granted -
US 12091411
IRAK degraders and uses thereof
granted -
US 12077555
STAT degraders and uses thereof
granted -
US 12006329
Protein degraders and uses thereof
granted -
US 11932624
MDM2 degraders and uses thereof
granted -
US 11932635
CRBN ligands and uses thereof
granted -
US 11857535
Methods of treating mutant lymphomas
granted -
US 11807636
IRAK degraders and uses thereof
granted -
US 11779578
IRAK degraders and uses thereof
granted -
US 11773103
IRAK4 degraders and uses thereof
granted -
US 11746120
Stat degraders and uses thereof
granted -
US 11723980
IRAK degraders and uses thereof
granted -
US 11707457
IRAK degraders and uses thereof
granted -
US 11685750
Crystalline forms of IRAK degraders
granted -
US 11679109
SMARCA degraders and uses thereof
granted -
US 11623932
Protein degraders and uses thereof
granted -
US 11591332
IRAK degraders and uses thereof
granted -
US 11512080
CRBN ligands and uses thereof
granted -
US 11485750
STAT degraders and uses thereof
granted